{"id":19866,"date":"2021-02-11T11:37:58","date_gmt":"2021-02-11T08:37:58","guid":{"rendered":"https:\/\/buletin.de\/bucuresti\/?p=19866"},"modified":"2021-03-02T18:43:07","modified_gmt":"2021-03-02T15:43:07","slug":"vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino","status":"publish","type":"post","link":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/","title":{"rendered":"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d"},"content":{"rendered":"\n

\u0218ocul pandemiei de COVID-19 asupra sistemului medical a lovit la fel de tare, \u00eens\u0103 cu \u00eent\u00e2rziere, \u0219i \u00een domeniul farmaceutic. Goana dup\u0103 vaccin a marilor juc\u0103tori \u00eenseamn\u0103, \u00eenainte de profituri substan\u021biale, investi\u021bii pe m\u0103sur\u0103 \u00een cercetare \u0219i dezvoltare. Dar \u0219i personal \u00eenalt calificat pentru o astfel de misiune.<\/strong> <\/p>\n\n\n\n

Aflat \u00een deriv\u0103 de ani de zile, Institutul Cantacuzino din Capital\u0103, institu\u021bia-amiral a cercet\u0103rii de profil din Rom\u00e2nia, a ajuns din nou pe agenda politicienilor \u00een contextul campaniei na\u021bionale de vaccinare.<\/p>\n\n\n\n

\u201cNoi vom \u00eencerca s\u0103 producem vaccinul la Cantacuzino. Ne-am ar\u0103tat disponibilitatea, am trimis o scrisoare oficialilor europeni, a\u0219tept\u0103m s\u0103 afl\u0103m ce vaccin am putea produce<\/em>\u201d, a dezv\u0103luit premierul Florin C\u00ee\u021bu, dup\u0103 ce a fost vaccinat cu ultima doza din serul produs \u00een Occident.<\/p>\n\n\n\n

C\u00e2t de fundamentat\u0103 este o astfel de declara\u021bie, \u00een contextul \u00een care Institutul Cantacuzino nu mai are nici m\u0103car licen\u021b\u0103 de fabrica\u021bie pentru vaccinuri generice, am aflat de profesorul Ioan Tomu\u021b\u0103, <\/em>expert \u00een industria farmaceutic\u0103. <\/p>\n\n\n\n

Perspectiva producerii unui vaccin anti-COVID \u00een Rom\u00e2nia, la Institutul Cantacuzino, fie prin metoda clasic\u0103, fie prin tehnologia ARN Mesager, \u00eenseamn\u0103 pe l\u00e2ng\u0103 echipamentele speciale \u0219i personal \u00eenalt calificat \u0219i o serie de autoriz\u0103ri \u0219i verific\u0103ri la s\u00e2nge.<\/p>\n\n\n\n

Doctor \u00een tehnologie farmaceutic\u0103 industrial\u0103 \u0219i specialist \u00een forme de farmaceutice inovatoare, profesorul Ioan Tomu\u021b\u0103 a p\u0103storit genera\u021bii de speciali\u0219ti care au ie\u0219it pe por\u021bile Universit\u0103\u021bile de Medicin\u0103 \u0219i Farmacie din Cluj-Napoca.<\/p>\n\n\n\n

\"\"
Profesorul Ioan Tomu\u021b\u0103 este specializat \u00een tehnologie farmaceutic\u0103 industrial\u0103. (FOTO: arhiva personal\u0103)<\/figcaption><\/figure>\n\n\n\n

Parte dintre ace\u0219tia au doctorate \u00een domeniu \u0219i lucreaz\u0103 acum \u00een companii consacrate din industria farmaceutic\u0103 occidental\u0103, fie \u00een produc\u021bie, fie \u00een cercetare.<\/p>\n\n\n\n

– Este Rom\u00e2nia preg\u0103tit\u0103, prin Institutul Cantacuzino, sa produc\u0103 vaccinuri anti-COVID?<\/strong><\/h4>\n\n\n\n

–  Dac\u0103 ne referim strict la tehnologia ARN mesager, a celor de la Pfizer-BioNTech, care au fost primii care au utilizat-o \u00een fabricarea de vaccinuri, eu cred c\u0103 nicio \u021bar\u0103 nu este cu mult mai bine preg\u0103tit\u0103 ca Romania s\u0103 fabrice, pentru c\u0103 nu sunt \u00eenc\u0103 suficien\u021bi speciali\u0219ti. Este o tehnologie cu totul nou\u0103 care presupune at\u00e2t linii speciale de fabrica\u021bie c\u00e2t \u0219i personal specializat pe aceste lunii. M\u0103 refer la personal cu studii superioare, adic\u0103 supervizor de produc\u021bie, \u0219i personal cu studii medii, adic\u0103 operatori, care s\u0103 \u0219tie s\u0103 utilizeze echipamentele specifice acestei tehnologii.<\/strong> C\u00e2nd am spus \u201dnu sunt \u00eenc\u0103 suficien\u021bi speciali\u0219ti\u201d m-am referit strict pentru fabricarea la scara industrial\u0103, \u00een mai multe locuri de fabrica\u021bie, pentru a acoperi necesarul actual de vaccinuri. Acesta este \u0219i motivul pentru care nici Pfizer-BioNTech nu s-a angajat c\u0103 va fabrica foarte repede cantit\u0103\u021bile mari solicitate.<\/em><\/p>\n\n\n\n

\"\"
Conferin\u021ba de pres\u0103 organizat\u0103 la Institutul Cantacuzino, cu ocazia sosirii primului lot de vaccin anti-COVID. (FOTO: Inquam Photos\/George C\u0103lin) <\/figcaption><\/figure>\n\n\n\n

– De c\u00e2t timp este pe pia\u021b\u0103 aceast\u0103 tehnologie?<\/strong><\/h4>\n\n\n\n

–  Primele studii au fost publicate \u00een 2006-2007. \u00cens\u0103 \u00een ceea prive\u0219te tehnologia ARN Mesager,  exist\u0103 actualmente foarte multe studii clinice \u00een desf\u0103\u0219urare, \u00een diferite etape, dat pentru tratarea cancerului. Pe pia\u021ba, eu nu \u0219tiu s\u0103 mai existe un medicament fabricat prin aceast\u0103 tehnologie. \u00cen privin\u021ba Institutului Cantacuzino, depinde ce se dore\u0219te. Din punctul meu de vedere cred ca tehnologia ARN Mesager ar trebui s\u0103 fie direc\u021bia corect\u0103, pentru c\u0103, din punctul meu de vedere este tehnologie secolului 21 \u00een fabricarea vaccinurilor. Dac\u0103 avem personal calificat \u00een Rom\u00e2nia? R\u0103spunsul este nu. \u00cens\u0103 nici al\u021bii nu au o astfel de resurs\u0103 uman\u0103 \u00eenc\u0103.<\/strong> Este adev\u0103rat c\u0103 formarea personalului necesit\u0103 timp, investi\u021bii, dar \u0219i o ac\u021biune coerent\u0103 \u00een acest domeniu, iar Romania nu exceleaz\u0103 la niciun capitol. Din p\u0103cate, pentru industria farmaceutic\u0103 eu n-am v\u0103zut politici \u0219i ac\u021biuni coerente a guvernan\u021bilor din ultimii 10 ani. Industria rom\u00e2neasc\u0103 de medicamente are mult de suferit \u0219i pe tehnologii clasice, care sunt de ani buni pe pia\u021ba, nu pe tehnologii de ultim\u0103 or\u0103. Produc\u021bia rom\u00e2neasc\u0103 de medicamente, m\u0103 refer la num\u0103rul de unit\u0103\u021bi fabricate, este din p\u0103cate \u00een ultimii ani \u00een sc\u0103dere continu\u0103. \u00cenainte, adic\u0103 p\u00e2n\u0103 prin 2010, era numai o sc\u0103dere a ponderii industrie rom\u00e2ne\u0219ti raportate la consumul total de medicamente din Romania, dar at\u00e2t valoric c\u00e2t \u0219i ca num\u0103r de unit\u0103\u021bi fabricate se \u00eenregistrau cre\u0219teri anuale constant. Ast\u0103zi, din cauza politicilor guvernamentale deficitare din acest domeniu. produc\u0103torii rom\u00e2ni de medicamente au ajuns s\u0103 nu aib\u0103 bani de investi\u021bii, E vorba de investi\u021bii \u00een infrastructur\u0103, pentru a men\u021bine unit\u0103\u021bile de fabrica\u021bie la un nivel tehnologic similare cu cel din Vest \u0219i investi\u021bii \u00een dezvoltarea de noi medicamente.<\/em><\/p>\n\n\n\n

 <\/em>– Aici putem include \u0219i medicamentele care sunt folosite \u00een terapia pentru COVID-19?<\/strong><\/h4>\n\n\n\n

 – Da. Acum se discut\u0103 despre Ivermectin\u0103, care se folose\u0219te curent \u00een medicina veterinar\u0103. Substan\u021ba respectiv\u0103 este cunoscut\u0103 de foarte mult timp. Nu este foarte complicat de transformat \u00een medicamente de uz uman. \u00cen Rom\u00e2nia avem facilit\u0103\u021bi pentru producerea de injectabile pentru uz uman. <\/strong>Totul depinde \u00eens\u0103 de viteza cu care se autorizeaz\u0103, respectiv de durata studiilor clinice necesare pentru dovedirea eficacit\u0103\u021bii \u0219i siguran\u021bie \u00een noua indica\u021bie terapeutic\u0103.<\/em><\/p>\n\n\n\n

\"\"
De la un produc\u0103tor consacrat de vaccinuri, Institutul Cantacuzino a ajuns doar s\u0103 de\u021bin\u0103 licen\u021b\u0103 de depozitare. (FOTO: Inquam Photos\/George C\u0103lin) <\/figcaption><\/figure>\n\n\n\n

 –  La aceast\u0103 or\u0103 Institutul Cantacuzino are doar o licen\u021b\u0103 de distribu\u021bie a vaccinurilor…<\/strong><\/h4>\n\n\n\n

 – Asta este cu totul altceva. Cantacuzino a ob\u021binut licen\u021ba la fel ca orice distribuitor de medicamente, dar strict numai pentru distribu\u021bia de vaccinuri. Orice depozit de medicamente are o astfel de licen\u021b\u0103, pentru putea distribui medicamente \u00een mod legal.<\/em><\/p>\n\n\n\n

\"\"
Institutul Cantacuzino mai produce ast\u0103zi doar suplimente alimentare. (FOTO: Inquam Photos\/Sabin Cirstoveanu)<\/figcaption><\/figure>\n\n\n\n

 –  Ce pa\u0219i trebuie urma\u021bi pentru ca la Cantacuzino s\u0103 se produc\u0103 vaccinuri anti-COVID pe metoda clasic\u0103, nu neap\u0103rat prin tehnologia ARN mesager?<\/strong><\/h4>\n\n\n\n

 – Este o cale foarte lung\u0103. \u00cen primul r\u00e2nd Institutul trebuie reautorizat GMP (nr.- Good Manufacturing Practice\/Certificat de Bun\u0103 Practic\u0103). Asta \u00eenseamn\u0103 echipamente, personal calificat \u0219i proceduri de utilizare pentru echipamente. Certificatul de Bun\u0103 Practic\u0103 este acordat de Agen\u021bia Na\u021bional\u0103 a Medicamentului \u0219i Dispozitivelor Medicale (n.r. – ANMDM), \u00een urma unei inspec\u021bii favorabile. El a fost suspendat acum c\u00e2\u021biva ani pentru c\u0103 Institutul nu mai \u00eendeplinea condi\u021biile.<\/strong> Ca urmare,  cred c\u0103 este necesar\u0103 o nou\u0103 facilitate de produc\u021bie.<\/em><\/p>\n\n\n\n

 –  Se ob\u021bine greu un astfel de certificat de bun\u0103 practic\u0103?<\/strong><\/h4>\n\n\n\n

 – Dac\u0103 ai echipamente \u0219i personal calificat nu se ob\u021bine greu.  Agen\u021bia Na\u021bional\u0103 a Medicamentului vine \u00een inspec\u021bie, te verific\u0103 \u0219i dac\u0103 constat\u0103 c\u0103 respec\u021bi cerin\u021bele Ghidului de Bun\u0103 Practic\u0103 de Fabrica\u021bie, \u00ee\u021bi acord\u0103 certificatul. Al doilea lucru de care ai nevoie este o Autoriza\u021bie de Punere pe Pia\u021b\u0103 (n.r. – APP) pentru vaccin. Aici discut\u0103m de fabricarea, pe linia certificat\u0103 GMP \u00een prealabil, a a\u0219a-numitelor serii pilot, care nu sunt distribuite popula\u021biei. Practic, pe linia certificat\u0103 GMP trebuie fabricate minim trei serii pilot <\/strong>prin care produc\u0103torul demonstreaz\u0103 c\u0103 poate fabrica acel medicamente sau vaccin <\/strong><\/em>\u00een condi\u021bii reproductibile \u0219i produsul fabricat \u00eendepline\u0219te toate caracteristicile prototipului utilizat \u00een studii clinice. Pe baza datelor ob\u021binute, se face ulterior documenta\u021bia pentru ob\u021binerea autoriza\u021biei de punere pe pia\u021b\u0103.<\/em>   <\/p>\n\n\n\n

\"\"
Institutul Cantacuzino a r\u0103mas f\u0103r\u0103 licen\u021b\u0103 de producere a vaccinurilor \u00een 2010. (FOTO: Inquam Photos\/Octav Ganea)<\/figcaption><\/figure>\n\n\n\n

 – Vorbim de acela\u0219i scenariu \u0219i \u00een cazul licen\u021bei de produc\u021bie?<\/strong><\/h4>\n\n\n\n

 –  Da. \u00cen domeniul farmaceutic se nume\u0219te fabricare sub contract. Produc\u0103torul Pfizer-BioNTech dac\u0103 dore\u0219te, \u0219i dac\u0103 noi am avea o facilitate de produc\u021bie, poate fie s\u0103 ne solicite s\u0103 fabric\u0103m pentru ei (ca loc de fabrica\u021bie suplimentar ad\u0103ugat la APP-ul deja existent), fie s\u0103 ne acorde licen\u021b\u0103 pentru a ob\u021bine un APP nou, destinat doar acestui loc de fabrica\u021bie. Dar \u0219i ambele cazuri este necesar\u0103 o facilitate de produc\u021bie.  <\/strong>Pentru o ac\u021biune similar\u0103 BioNTech a achizi\u021bionat de cur\u00e2nd o linie de fabrica\u021bie \u00een Elve\u021bia. Cunosc\u00e2nd domeniul, v\u0103 pot spune c\u0103 dac\u0103 se gr\u0103besc \u0219i nu au probleme tehnologice, este nevoie de minimum trei luni pentru a implementa tehnologia pe care au \u0219i o folosesc deja \u00een alte facilit\u0103\u021bi, pe linia de fabrica\u021bie achizi\u021bionat\u0103 din Elve\u021bia. Dup\u0103 implementare, este nevoie de \u00eentocmirea documenta\u021bie care trebuie depus\u0103 la EMA (n.r. European Medicines Agency) \u00een vederea ad\u0103ug\u0103rii a facilit\u0103\u021bii din Elve\u021bia ca loc de fabrica\u021bie suplimentar la APP-ul existent.<\/em><\/p>\n\n\n\n

 – Totu\u0219i, din p\u0103cate, Institutul Cantacuzino nu se afl\u0103 \u00een Elve\u021bia…<\/strong><\/p>\n\n\n\n

 – Noi dac\u0103 vrem s\u0103 producem acum vaccin folosind tehnologia Pfizer-BioNTech la Institutul Cantacuzino, din punctul meu de vedere, este aproape imposibil. <\/strong>Noi, \u00een primul r\u00e2nd, nu avem o astfel de facilitate \u00een Rom\u00e2nia, iar pentru a o realiza este nevoie pentru \u00eenceput de autoriza\u021bie de construire, apoi facilitatea trebuie construit\u0103. Aici m\u0103 refer at\u00e2t la cl\u0103dire, c\u00e2t \u0219i la compartimentare interioar\u0103 sau dotare cu echipamente adecvate. La final este necesar\u0103 autorizarea facilit\u0103\u021bii de c\u0103tre ANMDM, adic\u0103 acordarea certificatului GMP. Abia dup\u0103 autorizarea facilit\u0103\u021bii de c\u0103tre ANMDM, ai dreptul s\u0103 faci transferul tehnologic <\/strong>care s\u0103-\u021bi permit\u0103 s\u0103 fabrici seriile pilot \u00een baza c\u0103rora se \u00eentocme\u0219te documenta\u021bia pentru autoriza\u021bia de punere pe pia\u021b\u0103.<\/em><\/p>\n\n\n\n

\"\"
\u00cen contextul pandemiei de COVID-19, Institutul Cantacuzino a fost vizitat de mai multe ori de oficialii statului.(FOTO: Inquam Photos\/Octav Ganea) <\/figcaption><\/figure>\n\n\n\n

 – Cum crede\u021bi c\u0103 ar trebui abordat\u0103 aceast\u0103 problem\u0103, strict cu privire la Institutul Cantacuzino?<\/strong><\/h4>\n\n\n\n

 –  Dincolo de vaccinul anti-COVID, care este de foarte mare necesitate \u00een aceast\u0103 perioad\u0103, cred c\u0103 problema ar trebui abordat\u0103 ca perspectiv\u0103, \u00een sensul c\u0103 ar trebui stabilit ce vaccinuri se consider\u0103 c\u0103 sunt necesare s\u0103 fie fabricate la Institutul Cantacuzino \u00een urm\u0103torii 10-20 de ani, spre exemplu. Eu a\u0219 \u00eencepe dezvoltarea unui Centru de Excelen\u021b\u0103 \u00een Cercetare, \u00een domeniul vaccinurilor, bazat pe tehnologia ARN Mesager, c\u0103ruia s\u0103 i se asocieze ulterior o linie de fabrica\u021bie, <\/strong>iar activitatea principal\u0103 a Institutului Cantacuzino c\u0103 fie cercetarea nu produc\u021bia. Cred c\u0103 aceasta ar fi cea mai bun\u0103 abordare pentru relansarea Institutului Cantacuzino.<\/em><\/p>\n\n\n\n

 –  Ca profesor \u0219i conduc\u0103tor de doctorate \u00een acest domeniu, crede\u021bi c\u0103 Rom\u00e2nia poate asigura la aceast\u0103 or\u0103 profesioni\u0219tii necesari pentru acest scenariu?<\/strong><\/h4>\n\n\n\n

 <\/strong>–  Nu cred ca este o problem\u0103 dac\u0103 ne referim strict la partea de fabrica\u021bie. Problema Rom\u00e2niei cu personalul \u00eenalt calificat este alta: profesioni\u0219tii nu stau \u00een Rom\u00e2nia. <\/strong>Din punctul meu de vedere aceasta este o problema mult mai grav\u0103. Mul\u021bi profesioni\u0219ti, \u0219i aici m\u0103 refer strict la cei din domeniul farmaceutic dup\u0103 ce termin\u0103 doctoratul nu reu\u0219esc s\u0103 g\u0103seasc\u0103 \u00een Rom\u00e2nia un loc de munc\u0103 adecvat calific\u0103rii lor, \u0219i ca urmare pleac\u0103 \u0219i profeseaz\u0103 \u00een alt\u0103 \u021bar\u0103.<\/em><\/p>\n\n\n\n

 – Avem \u00een momentul de fa\u021b\u0103 speciali\u0219ti rom\u00e2ni care lucreaz\u0103 \u00een cercetare la aceste companii care produc vaccinuri anti-COVID?<\/strong><\/h4>\n\n\n\n

 <\/strong>–  Nu \u0219tiu acest lucru. Cel pu\u021bin dintre absolven\u021bii no\u0219tri, nu \u0219tiu s\u0103 lucreze cineva la Pfizer-BioNTech sau Moderna.<\/em><\/p>\n\n\n\n

\"\"
Vaccinurile anti-COVID pot fi produse pe baza a dou\u0103 tehnologii diferite: cea clasic\u0103, prin vector viral nereplicativ, \u0219i cea prin ARN Mesager. (FOTO: Inquam Photos\/Costin Dinc\u0103)<\/figcaption><\/figure>\n\n\n\n

 –  Ce salarii sunt pentru astfel de speciali\u0219ti, la nivel european?<\/strong><\/h4>\n\n\n\n

 <\/strong>–  Ce v\u0103 pot spune e c\u0103 la nivelul Rom\u00e2niei, industria farmaceutic\u0103 nu ofer\u0103 predictibilitate \u0219i nu are, din p\u0103cate, for\u021ba financiar\u0103 s\u0103 pl\u0103teasc\u0103 bine \u0219i s\u0103 atrag\u0103 cei mai buni speciali\u0219ti. Consecin\u021ba e c\u0103 cei mai buni speciali\u0219ti aleg s\u0103 lucreze \u00een str\u0103in\u0103tate. Pe partea tehnologiei ARN Mesager nu cunosc, \u00eens\u0103 ce \u0219tiu de la colegi, fo\u0219ti absolven\u021bi, care lucreaz\u0103 \u00een companii farmaceutice din str\u0103in\u0103tate, doar la plecare angajatorii ofer\u0103 din start minimum 4.000 de euro. Ulterior salariile cresc, \u00een func\u021bie de experien\u021b\u0103 \u0219i domeniu\/pozi\u021bie ocupat\u0103, pot dep\u0103\u0219i chiar \u0219i 10.000 de euro.<\/strong> Salariile depind \u0219i de costurile traiului zilnic din \u021bara unde este compania angajatoare.  Din p\u0103cate, a\u0219a cum v-am spus, industria farmaceutic\u0103 din Rom\u00e2nia nu poate concura cu nivelul acesta de salarizare, \u00een condi\u021biile \u00een care pre\u021bul multor medicamente generice este plafonat de guvern la 3-4 lei.   <\/p>\n\n\n\n

 – \u00cen acest context, cum a\u021bi cataloga anun\u021burile guvernamentale privind producerea de vaccin anti-COVID la Cantacuzino?<\/strong><\/h4>\n\n\n\n

 –  Nu \u0219tiu dac\u0103 persoanele care fac astfel de declara\u021bii \u0219tiu ce \u00eenseamn\u0103 producerea de vaccinuri. Cred c\u0103 nu. \u00cens\u0103 eu iau partea pozitiv\u0103 \u0219i anume c\u0103 ace\u0219ti oameni chiar \u00ee\u0219i doresc ca acest lucru s\u0103 fie posibil \u00een Romania \u0219i se str\u0103duiesc s\u0103 fac\u0103 ceva. Dar, ca de multe ori \u00een via\u021b\u0103 este o mare diferen\u021b\u0103, \u00eentre  dorin\u021b\u0103 \u0219i putin\u021b\u0103. P\u0103rerea mea e ca \u00eenainte de a face astfel de declara\u021bii ar fi bine sa fie sf\u0103tui\u021bi de consilieri cu experien\u021b\u0103 \u00een domeniu. Este de bun augur c\u0103 se dore\u0219te acest lucru, \u00eens\u0103 totul pleac\u0103 de la o politic\u0103 coerent\u0103 pe termen lung pentru a putea fabrica vaccin \u00een Rom\u00e2nia \u00een viitor. Adic\u0103 politica s\u0103 \u00eenceap\u0103 acum, \u00een 2021, \u0219i s\u0103 nu se schimbe, dac\u0103 se schimb\u0103 guvernul sau ministrul s\u0103n\u0103t\u0103\u021bii. <\/strong>Eu cred c\u0103 \u00een cinci ani se pot vedea primele rezultate iar \u00eentr-un interval de 10-15 ani, acestea pot fi excelente. Din ce am discutat cu colegii mai tineri, exista dorin\u021ba de a pleca \u00een str\u0103in\u0103tate tocmai din cauza unor politici guvernamentale necoerente \u00een domeniul cercet\u0103rii sau farmaceutic, care pe termen lung \u00eensemn\u0103 lips\u0103 de predictibilitate \u0219i nesiguran\u021b\u0103 pentru speciali\u0219ti. Ei consider\u0103 c\u0103 e mai bine s\u0103 plece la 30-35 de ani, c\u00e2nd sunt \u00eenc\u0103 tineri dar complet forma\u021bi din punct de vedere profesional, ca s\u0103 \u00ee\u0219i dezvolte o carier\u0103 profesional\u0103 acolo, dec\u00e2t s\u0103 r\u0103m\u00e2n\u0103 \u0219i s\u0103 se trezeasc\u0103 c\u0103 la un moment dat c\u0103 se taie fondurile pentru un proiect de cercetare aflat \u00een desf\u0103\u0219urare, sau nu se mai deschide nicio competi\u021bie de proiecte pentru o perioad\u0103 de 3-4 ani ca s\u0103 poat\u0103 s\u0103 \u00ee\u0219i continue activitatea. E vorba practic de predictibilitatea carierei profesionale pe termen lung. De cealalt\u0103 parte, prin companiile farmaceutice europene sunt destul de mul\u021bi rom\u00e2ni cu experien\u021b\u0103 profesional\u0103 foarte bogat\u0103 care, prin politici coerente \u0219i pe termen lung, ar putea fi convin\u0219i s\u0103 se \u00eentoarc\u0103 s\u0103 lucreze acas\u0103 \u0219i astfel s\u0103 fie valorificat\u0103 experien\u021ba profesional\u0103 acumulat\u0103 \u00een str\u0103in\u0103tate.<\/em><\/p>\n\n\n\n

\"\"
“Noi vom \u00eencerca s\u0103 producem vaccinul la Cantacuzino<\/em>“, a declarat prim-ministrul Florin C\u00ee\u021bu dupa ce a primit rapelul vaccinului anti COVID-19. (FOTO: Inquam Photos\/Sabin Cirstoveanu)<\/figcaption><\/figure>\n\n\n\n

 – \u00cen cazul \u00een care, printr-o minune, \u00een Rom\u00e2nia s-ar rezolva peste noapte toate aceste probleme pe care le-a\u021bi amintit, c\u00e2nd am putea aveam, spre exemplu, un vaccin anti-COVID autohton?<\/strong><\/h4>\n\n\n\n

 – \u00cen regie proprie, adic\u0103 dezvoltat \u00een Romania,  cred ca ar dura 10-15 ani. Pentru a-l face \u00eens\u0103 sub licen\u021ba de produc\u021bie, adic\u0103 fabricat \u00een colaborare cu unul dintre marii juc\u0103tori care au tehnologia de fabrica\u021bie, dac\u0103 lucrurile merg bine, \u00eentr-un an cred s-ar putea realiza.<\/em><\/p>\n\n\n\n

FOTO: Inquam Photos\/Octav Ganea<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

\u0218ocul pandemiei de COVID-19 asupra sistemului medical a lovit la fel de tare, \u00eens\u0103 cu \u00eent\u00e2rziere, \u0219i \u00een domeniul farmaceutic. Goana dup\u0103 vaccin a marilor juc\u0103tori \u00eenseamn\u0103, \u00eenainte de profituri substan\u021biale, investi\u021bii pe m\u0103sur\u0103 \u00een cercetare \u0219i dezvoltare. Dar \u0219i personal \u00eenalt calificat pentru o astfel de misiune. Aflat \u00een deriv\u0103 de ani de zile, […]<\/p>\n","protected":false},"author":10,"featured_media":19880,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"ngg_post_thumbnail":0,"footnotes":""},"categories":[4],"tags":[2251,2043,640,2254,2250,2252,2253,1388],"ppma_author":[22575],"class_list":["post-19866","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sanatate","tag-arn-mesager","tag-cantacuzino","tag-covid","tag-fabricare","tag-licenta","tag-productie","tag-serii-pilot","tag-vaccin"],"acf":[],"a3_pvc":{"activated":false,"total_views":0,"today_views":0},"yoast_head":"\nVaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d - Buletin de Bucure\u0219ti<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d\" \/>\n<meta property=\"og:description\" content=\"\u0218ocul pandemiei de COVID-19 asupra sistemului medical a lovit la fel de tare, \u00eens\u0103 cu \u00eent\u00e2rziere, \u0219i \u00een domeniul farmaceutic. Goana dup\u0103 vaccin a marilor juc\u0103tori \u00eenseamn\u0103, \u00eenainte de profituri substan\u021biale, investi\u021bii pe m\u0103sur\u0103 \u00een cercetare \u0219i dezvoltare. Dar \u0219i personal \u00eenalt calificat pentru o astfel de misiune. Aflat \u00een deriv\u0103 de ani de zile, […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/\" \/>\n<meta property=\"og:site_name\" content=\"Buletin de Bucure\u0219ti\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/buletin.de.buc\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-11T08:37:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-02T15:43:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/ID83327_INQUAM_Photos_Octav_Ganea-900x600.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"C\u0103t\u0103lin Dosca\u0219\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"C\u0103t\u0103lin Dosca\u0219\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"13 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/\"},\"author\":{\"name\":\"C\u0103t\u0103lin Dosca\u0219\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#\\\/schema\\\/person\\\/31117187ed4d0bdb0a4c7d6acc79d0f8\"},\"headline\":\"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d\",\"datePublished\":\"2021-02-11T08:37:58+00:00\",\"dateModified\":\"2021-03-02T15:43:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/\"},\"wordCount\":2684,\"publisher\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/ID83327_INQUAM_Photos_Octav_Ganea.jpg\",\"keywords\":[\"arn mesager\",\"Cantacuzino\",\"covid\",\"fabricare\",\"licenta\",\"productie\",\"serii pilot\",\"vaccin\"],\"articleSection\":[\"S\u0103n\u0103tate\"],\"inLanguage\":\"en-GB\",\"copyrightYear\":\"2021\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/\",\"name\":\"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d - Buletin de Bucure\u0219ti\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/ID83327_INQUAM_Photos_Octav_Ganea.jpg\",\"datePublished\":\"2021-02-11T08:37:58+00:00\",\"dateModified\":\"2021-03-02T15:43:07+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#primaryimage\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/ID83327_INQUAM_Photos_Octav_Ganea.jpg\",\"contentUrl\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/ID83327_INQUAM_Photos_Octav_Ganea.jpg\",\"width\":2000,\"height\":1334},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Acas\u0103\",\"item\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#website\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/\",\"name\":\"Buletin de Bucure\u0219ti\",\"description\":\"\u0218tiri \u0219i investiga\u021bii esen\u021biale din capital\u0103\",\"publisher\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#organization\",\"name\":\"Buletin de Bucure\u0219ti\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/logo-bdb-full-wide-vernil-transparent.png\",\"contentUrl\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/logo-bdb-full-wide-vernil-transparent.png\",\"width\":1782,\"height\":626,\"caption\":\"Buletin de Bucure\u0219ti\"},\"image\":{\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/buletin.de.buc\",\"https:\\\/\\\/www.instagram.com\\\/buletinde.bucuresti\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/#\\\/schema\\\/person\\\/31117187ed4d0bdb0a4c7d6acc79d0f8\",\"name\":\"C\u0103t\u0103lin Dosca\u0219\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/Catalin-Doscas-e1732731064764-96x96.jpga93e2943bb3b1c1f9ead823df6e6317a\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/Catalin-Doscas-e1732731064764-96x96.jpg\",\"contentUrl\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/wp-content\\\/uploads\\\/Catalin-Doscas-e1732731064764-96x96.jpg\",\"caption\":\"C\u0103t\u0103lin Dosca\u0219\"},\"description\":\"Reporter \u0219i redactor-\u0219ef Buletin de Bucure\u0219ti. Lucreaz\u0103 \u00een mass-media de la v\u00e2rsta de 15 ani, c\u00e2nd a publicat primele articole \u00een presa local\u0103 din Tecuci. \u00cen Bucure\u0219ti a lucrat \u00een redac\u021bii radio ca reporter, redactor \u0219i prezentator (StudentFM, Na\u021bionalFM, Radio Total, Smart FM), unde a acoperit domeniile politic, economic, social \u0219i externe. Ulterior, a fost editor-coordonator al postului Realitatea FM. Experien\u021ba \u00een jurnalismul online a dob\u00e2ndit-o la portalul B365.ro, unde a fost editor. \u00cen 2012 s-a angajat \u00een televiziune. La Realitatea TV a fost, pe r\u00e2nd, reporter la sec\u021bia Social, reporter special la emisiunea de reportaje \u0219i anchete \u201eReporterii Realit\u0103\u021bii\u201d, dar \u0219i editor al jurnalelor de \u0219tiri. Ulterior, a f\u0103cut parte din sec\u021bia de Investiga\u021bii de la Digi24 \u0219i a lucrat la campania \u201eRom\u00e2nia furat\u0103\u201d. A revenit \u00een presa scris\u0103 \u00een 2017, ca reporter special, \u00een cadrul unui proiect de repozi\u021bionare a tabloidului Libertatea \u00een cotidian generalist. Este jurnalist Buletin de Bucure\u0219ti din 2019.\",\"url\":\"https:\\\/\\\/buletin.de\\\/bucuresti\\\/author\\\/catalin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d - Buletin de Bucure\u0219ti","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/","og_locale":"en_GB","og_type":"article","og_title":"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d","og_description":"\u0218ocul pandemiei de COVID-19 asupra sistemului medical a lovit la fel de tare, \u00eens\u0103 cu \u00eent\u00e2rziere, \u0219i \u00een domeniul farmaceutic. Goana dup\u0103 vaccin a marilor juc\u0103tori \u00eenseamn\u0103, \u00eenainte de profituri substan\u021biale, investi\u021bii pe m\u0103sur\u0103 \u00een cercetare \u0219i dezvoltare. Dar \u0219i personal \u00eenalt calificat pentru o astfel de misiune. Aflat \u00een deriv\u0103 de ani de zile, […]","og_url":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/","og_site_name":"Buletin de Bucure\u0219ti","article_publisher":"https:\/\/www.facebook.com\/buletin.de.buc","article_published_time":"2021-02-11T08:37:58+00:00","article_modified_time":"2021-03-02T15:43:07+00:00","og_image":[{"width":900,"height":600,"url":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/ID83327_INQUAM_Photos_Octav_Ganea-900x600.jpg","type":"image\/jpeg"}],"author":"C\u0103t\u0103lin Dosca\u0219","twitter_card":"summary_large_image","twitter_misc":{"Written by":"C\u0103t\u0103lin Dosca\u0219","Estimated reading time":"13 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#article","isPartOf":{"@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/"},"author":{"name":"C\u0103t\u0103lin Dosca\u0219","@id":"https:\/\/buletin.de\/bucuresti\/#\/schema\/person\/31117187ed4d0bdb0a4c7d6acc79d0f8"},"headline":"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d","datePublished":"2021-02-11T08:37:58+00:00","dateModified":"2021-03-02T15:43:07+00:00","mainEntityOfPage":{"@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/"},"wordCount":2684,"publisher":{"@id":"https:\/\/buletin.de\/bucuresti\/#organization"},"image":{"@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#primaryimage"},"thumbnailUrl":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/ID83327_INQUAM_Photos_Octav_Ganea.jpg","keywords":["arn mesager","Cantacuzino","covid","fabricare","licenta","productie","serii pilot","vaccin"],"articleSection":["S\u0103n\u0103tate"],"inLanguage":"en-GB","copyrightYear":"2021","copyrightHolder":{"@id":"https:\/\/buletin.de\/bucuresti\/#organization"}},{"@type":"WebPage","@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/","url":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/","name":"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d - Buletin de Bucure\u0219ti","isPartOf":{"@id":"https:\/\/buletin.de\/bucuresti\/#website"},"primaryImageOfPage":{"@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#primaryimage"},"image":{"@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#primaryimage"},"thumbnailUrl":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/ID83327_INQUAM_Photos_Octav_Ganea.jpg","datePublished":"2021-02-11T08:37:58+00:00","dateModified":"2021-03-02T15:43:07+00:00","breadcrumb":{"@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#primaryimage","url":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/ID83327_INQUAM_Photos_Octav_Ganea.jpg","contentUrl":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/ID83327_INQUAM_Photos_Octav_Ganea.jpg","width":2000,"height":1334},{"@type":"BreadcrumbList","@id":"https:\/\/buletin.de\/bucuresti\/vaccinul-romanesc-anti-covid-chiar-si-sub-licenta-de-fabricatie-este-aproape-imposibil-sa-se-produca-la-cantacuzino\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Acas\u0103","item":"https:\/\/buletin.de\/bucuresti\/"},{"@type":"ListItem","position":2,"name":"Vaccinul rom\u00e2nesc anti-COVID | \u201cChiar \u0219i sub licen\u021b\u0103 de fabrica\u021bie, este aproape imposibil s\u0103 se produc\u0103 la Cantacuzino\u201d"}]},{"@type":"WebSite","@id":"https:\/\/buletin.de\/bucuresti\/#website","url":"https:\/\/buletin.de\/bucuresti\/","name":"Buletin de Bucure\u0219ti","description":"\u0218tiri \u0219i investiga\u021bii esen\u021biale din capital\u0103","publisher":{"@id":"https:\/\/buletin.de\/bucuresti\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/buletin.de\/bucuresti\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/buletin.de\/bucuresti\/#organization","name":"Buletin de Bucure\u0219ti","url":"https:\/\/buletin.de\/bucuresti\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/buletin.de\/bucuresti\/#\/schema\/logo\/image\/","url":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/logo-bdb-full-wide-vernil-transparent.png","contentUrl":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/logo-bdb-full-wide-vernil-transparent.png","width":1782,"height":626,"caption":"Buletin de Bucure\u0219ti"},"image":{"@id":"https:\/\/buletin.de\/bucuresti\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/buletin.de.buc","https:\/\/www.instagram.com\/buletinde.bucuresti\/"]},{"@type":"Person","@id":"https:\/\/buletin.de\/bucuresti\/#\/schema\/person\/31117187ed4d0bdb0a4c7d6acc79d0f8","name":"C\u0103t\u0103lin Dosca\u0219","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/Catalin-Doscas-e1732731064764-96x96.jpga93e2943bb3b1c1f9ead823df6e6317a","url":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/Catalin-Doscas-e1732731064764-96x96.jpg","contentUrl":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/Catalin-Doscas-e1732731064764-96x96.jpg","caption":"C\u0103t\u0103lin Dosca\u0219"},"description":"Reporter \u0219i redactor-\u0219ef Buletin de Bucure\u0219ti. Lucreaz\u0103 \u00een mass-media de la v\u00e2rsta de 15 ani, c\u00e2nd a publicat primele articole \u00een presa local\u0103 din Tecuci. \u00cen Bucure\u0219ti a lucrat \u00een redac\u021bii radio ca reporter, redactor \u0219i prezentator (StudentFM, Na\u021bionalFM, Radio Total, Smart FM), unde a acoperit domeniile politic, economic, social \u0219i externe. Ulterior, a fost editor-coordonator al postului Realitatea FM. Experien\u021ba \u00een jurnalismul online a dob\u00e2ndit-o la portalul B365.ro, unde a fost editor. \u00cen 2012 s-a angajat \u00een televiziune. La Realitatea TV a fost, pe r\u00e2nd, reporter la sec\u021bia Social, reporter special la emisiunea de reportaje \u0219i anchete \u201eReporterii Realit\u0103\u021bii\u201d, dar \u0219i editor al jurnalelor de \u0219tiri. Ulterior, a f\u0103cut parte din sec\u021bia de Investiga\u021bii de la Digi24 \u0219i a lucrat la campania \u201eRom\u00e2nia furat\u0103\u201d. A revenit \u00een presa scris\u0103 \u00een 2017, ca reporter special, \u00een cadrul unui proiect de repozi\u021bionare a tabloidului Libertatea \u00een cotidian generalist. Este jurnalist Buletin de Bucure\u0219ti din 2019.","url":"https:\/\/buletin.de\/bucuresti\/author\/catalin\/"}]}},"authors":[{"term_id":22575,"user_id":10,"is_guest":0,"slug":"catalin","display_name":"C\u0103t\u0103lin Dosca\u0219","avatar_url":"https:\/\/buletin.de\/bucuresti\/wp-content\/uploads\/Catalin-Doscas-e1732731064764-96x96.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/posts\/19866","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/comments?post=19866"}],"version-history":[{"count":12,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/posts\/19866\/revisions"}],"predecessor-version":[{"id":20942,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/posts\/19866\/revisions\/20942"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/media\/19880"}],"wp:attachment":[{"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/media?parent=19866"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/categories?post=19866"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/tags?post=19866"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/buletin.de\/bucuresti\/wp-json\/wp\/v2\/ppma_author?post=19866"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}